Emory EGHI
Skip Navigation

Special Events and Programs

The Rotavirus Immunization Program Evaluation in Kenya (RIPEK)

ripek inset

Rotavirus is the most common cause of severe gastroenteritis among children under five years old worldwide. It is responsible for more than 450,000 deaths annually, with more than half of these deaths occurring in sub-Saharan Africa. In July 2014, with the support of Gavi, the Kenya Ministry of Health rolled out the use of rotavirus vaccine for children.

For two and a half years following vaccine introduction, EGHI’s Gavi-funded RIPEK project will monitor vaccine impact in Kenya, enabling the full documentation of the health and economic benefits of rotavirus vaccine against a range of clinical outcomes for diarrhea and, potentially, impact on death. EGHI’s in-country partners include the Walter Reed Army Institute of Research (WRAIR), the Kenya Medical Research Institute (KEMRI)-CDC, and KEMRI-Wellcome Trust.